Qnovia, Inc., a pharmaceutical and medtech company revolutionizing inhaled therapeutics, today announced positive results from its Phase 1 clinical trial evaluating the safety and efficacy of ...

Health technology assessment, or HTA, is how we figure out if new medical stuff is actually worth it. It’s supposed to help ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data at ...

Sixfold secured $30M Series B to advance its AI Underwriter, transforming how insurers quote, select risk, and scale ...

Three plan options with available discounts don’t balance out coverage exclusions, low coverage limits and mixed customer reviews. NerdWallet is committed to editorial integrityMany or all of the ...

We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving adults with acute, nonarteritic central retinal artery occlusion who had symptom onset within 4.5 hours ...

At NBC Select, we strive to help you find products that elevate your life. Today, we launched our third annual Best of Wellness Awards. To curate our list of winners we spent countless hours testing ...

Q4 2025 Earnings Call February 12, 2026 4:30 PM ESTCompany ParticipantsSean Christensen - Vice President of Finance and ...

CooperVision today announced immediate availability of its MiSight® 1 day* myopia control contact lens in Japan, where as many as 77% of elementary school children are estimated to be myopic, equating ...

What started off more than five years ago as one-off bans in individual classrooms grew into statewide efforts to curb student cellphone use during school. Now, the idea of limiting children’s tech ...

This article was co-authored with Emma Myer, a student at Washington and Lee University who studies Cognitive/Behavioral Science and Strategic Communication. In today’s digital age, social media has ...